Natus Medical to Hold 2010 First Quarter Financial Results Conference Call on April 29

* Reuters is not responsible for the content in this press release.

Thu Apr 22, 2010 7:00am EDT

SAN CARLOS, Calif.--(Business Wire)--
Natus Medical Incorporated (Nasdaq:BABY) today announced that the Company
intends to release its 2010 first quarter financial results before the market
opens on Thursday, April 29, 2010. Natus management will host an
investment-community conference call the same day beginning at 11:00 a.m.
Eastern Time (8:00 a.m. Pacific Time) to discuss those results and to answer
questions. 

Individuals interested in listening to the conference call may do so by dialing
800-573-4842 for domestic callers, or 1-617-224-4327 for international callers,
and entering reservation code 24416747. A telephone replay will be available for
48 hours following the conclusion of the call by dialing 888-286-8010 for
domestic callers, or 1-617-801-6888 for international callers, and entering
reservation code 97684604. 

The conference call also will be available real-time via the Internet at
http://investor.natus.com, and a recording of the call will be available on the
Company's Web site for 90 days following the completion of the call. 

About Natus Medical Incorporated

Natus is a leading provider of healthcare products used for the screening,
detection, treatment, monitoring and tracking of common medical ailments in
newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep
disorders, and balance and mobility disorders. Product offerings include
computerized neurodiagnostic systems for audiology, neurology, polysomnography,
and neonatology, as well as newborn care products such as hearing screening
systems, phototherapy devices for the treatment of newborn jaundice,
head-cooling products for the treatment of brain injury in newborns, and
software systems for managing and tracking disorders and diseases for public
health laboratories. 

Additional information about Natus Medical can be found at www.natus.com.

Natus Medical Incorporated
Director of Investor Relations
Brienne H. Fisher, 650-802-0400
InvestorRelations@Natus.com

Copyright Business Wire 2010

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.